Published in Drug Week, March 31st, 2006
Research published in Anesthesiology shows how the team safely gave xenon to 12 patients undergoing coronary artery bypass grafting while on cardiopulmonary artery bypass, a step which could eventually lead to new treatments for people suffering from illnesses that damage nerve cells, such as strokes, and brain and spinal cord injuries.
Earlier preclinical work by the team showed that xenon was effective as a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.